Keeping Current CME
Pediatric TRK Fusion-Positive Cancer: Optimizing Care With TRK Inhibitors
Are you up to date on the use of tropomyosin receptor kinase (TRK) inhibitors in pediatric patients with TRK fusion-positive cancers? Credit available for this activity expires: 11/29/25 Earn Credit /